Ticagrelor Versus Clopidogrel in Carotid Artery Stenting

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 210 participants.

Also called NCT02677545

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 210 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02677545
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium, Germany, Italy, Netherlands, Switzerland, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02677545. Randomized; no masking; primary purpose treatment. Start 2016-12 (actual); primary completion 2022-04-28 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ticagrelor Versus Clopidogrel in Carotid Artery Stenting
Acronym
PRECISE-MRI
Condition
Carotid Artery Stenosis
Intervention (Drug)
Ticagrelor
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Aspirin
Lead sponsor
University Hospital, Basel, Switzerland (class: other)

Record details

Record id
cardio:ct-nct02677545
Content hash
61eb65d31a04dbe745d228f36487deef4ab5cbfb9f88579a695f3fce011b13dd